April 22, 2026DrugsFDA
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. recalls MGC Health, Menthol- Cough Suppressant, Oral Anesthetic, Cough Drops, Honey Lemon, 80-count bag, Distributed By: Medical
Hazard: This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
April 22, 2026DrugsFDA
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. recalls MGC Health, Menthol- Cough Suppressant, Oral Anesthetic, Cough Drops, Honey Lemon, 30-count bag, Distributed By: Medical
Hazard: This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
April 22, 2026DrugsFDA
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. recalls MGC Health, Menthol- Cough Suppressant, Oral Anesthetic, Cough Drops, Sugar Free, Honey Lemon, 25-count bag, Distributed
Hazard: This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
April 22, 2026DrugsFDA
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. recalls Discount Drug Mart Food Market, Cough Drops, Menthol -Cough Suppressant Anesthetic, 30-count bag, Distributed By: Drug M
Hazard: This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
April 22, 2026DrugsFDA
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. recalls Discount Drug Mart Food Market, Cough Drops, Menthol- Cough Suppressant Anesthetic, Honey Lemon, 30-count bag, Distribut
Hazard: This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
April 22, 2026DrugsFDA
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. recalls caring mill, Menthol Cough Suppressant Oral Anesthetic, Cough Drops, Cherry, 90-count bag, Distributed by: FSA Store Inc
Hazard: This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
April 22, 2026DrugsFDA
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. recalls exchange select, Menthol- Cough Suppressant Oral Anesthetic, Cough Drops, Menthol Flavor, 30-count bag, Manufactured for
Hazard: This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
April 22, 2026DrugsFDA
Xiamen Kang Zhongyuan Biotechnology Co., Ltd. recalls exchange select, Menthol -Cough Suppressant Oral Anesthetic, Honey Lemon Flavor Cough Drops, 30-count bag, Manufactured
Hazard: This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
April 22, 2026DrugsFDA
Owen Biosciences Inc. recalls SLMD Benzoyl Peroxide Acne Lotion, Benzoyl Peroxide 2.5%, a) 0.7 fl. oz - 21 mL and b) 1.5 fl. oz. - 44mL bottles, SANDR
Hazard: Chemical contamination: Presence of benzene
April 22, 2026DrugsFDA
Owen Biosciences Inc. recalls SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide, 0.5 fl. oz - 15 mL bottles, Sandra Lee MD, Distributed by Skin PS Bra
Hazard: Chemical contamination: Presence of benzene
April 22, 2026DrugsFDA
Owen Biosciences Inc. recalls HydroPeptide CLEAR ALLIANCE SERUM, 2.5% BENZOYL PEROXIDE, a)1 FL OZ/30ml; b) 2 FL OZ/60ml spray bottle; DIST BY HYDROPEP
Hazard: Chemical contamination: Presence of benzene
April 22, 2026DrugsFDA
Owen Biosciences Inc. recalls FHF Farmhouse Fresh, Midnight Clearing, NIGHT LOTION, 2.5% BENZOYL PEROXIDE ACNE TREATMENT, OTC a) 0.5 fl. oz./15ml; and
Hazard: Chemical contamination: Presence of benzene
April 22, 2026DrugsFDA
Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga,
Hazard: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
April 22, 2026DrugsFDA
Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga,
Hazard: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
April 22, 2026DrugsFDA
Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga,
Hazard: CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
April 15, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufact
Hazard: CGMP Deviations: use of an unapproved raw material
April 15, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufact
Hazard: CGMP Deviations: use of an unapproved raw material
April 15, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx Only, Manufact
Hazard: CGMP Deviations: use of an unapproved raw material
April 15, 2026DrugsFDA
GE Healthcare Ireland Limited recalls GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough
Hazard: Presence of particulate matter
April 15, 2026DrugsFDA
GE Healthcare Ireland Limited recalls GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough
Hazard: Presence of particulate matter
April 15, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc.
Hazard: Superpotent and Subpotent
April 15, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc.
Hazard: Superpotent and Subpotent
April 15, 2026DrugsFDA
Viatris, Inc. recalls Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC
Hazard: Failed Dissolution Specifications
April 15, 2026DrugsFDA
Preferred Pharmaceuticals, Inc. recalls Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg
Hazard: Lack of Assurance of Sterility
April 15, 2026DrugsFDA
Fagron Compounding Services recalls Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wi
Hazard: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
April 15, 2026DrugsFDA
Fagron Compounding Services recalls Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N.
Hazard: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
April 15, 2026DrugsFDA
Fagron Compounding Services recalls Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N
Hazard: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
April 15, 2026DrugsFDA
Fagron Compounding Services recalls norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N.
Hazard: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
April 15, 2026DrugsFDA
Fagron Compounding Services recalls norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. W
Hazard: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
April 15, 2026DrugsFDA
Fresenius Kabi USA, LLC recalls 5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius Kabi USA, LLC ("F
Hazard: Lack of Assurance of Sterility